HIV Infection and Obesity: A Review of the Evidence

Journal of the Association of Nurses in AIDS Care

Volumn 20, Issue 4, 2009, Pages 260-274

  Keithley, Joyce K ^a   Duloy, Anna M S ^a   Swanson, Barbara ^a   Zeller, Janice M ^a  

^a NONE

Author keywords

advanced clinical management; HIV infection; morbidities; obesity; overweight; predictive value; prevalence

Indexed keywords

ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; DISEASE COURSE; EVIDENCE BASED PRACTICE; EXERCISE; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; LOW CALORY DIET; MENTAL STRESS; METABOLIC SYNDROME X; MORBIDITY; NURSE ATTITUDE; OBESITY; PREDICTION AND FORECASTING; PREVALENCE; TREATMENT OUTCOME;

BODY COMPOSITION; BODY MASS INDEX; DIET, REDUCING; DISEASE PROGRESSION; ENERGY INTAKE; EVIDENCE-BASED PRACTICE; EXERCISE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LIFE STYLE; METABOLIC SYNDROME X; MORBIDITY; NURSE'S ROLE; OBESITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 67649306226     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2009.02.006     Document Type: Article

References (54)

1. Albu J.B., Kenya S., He Q., Wainwright M., Berk E.S., Heshka S., et al. Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women. American Journal of Clinical Nutrition 86 (2007) 100-106
2. Amorosa V., Synnestvedt M., Gross R., Friedman H., MacGregor R.R., Gudonis D., et al. A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. Journal of Acquired Immune Deficiency Syndromes 39 (2005) 557-561
3. Bjorntorp P. The regulation of adipose tissue distribution in humans. International Journal of Obesity and Related Metabolic Disorders 20 4 (1996) 291-302
4. Blass S.C., Ellinger S., Vogel M., Ingiliz P., Spengler U., Stehle P., et al. Overweight HIV patients with abdominal fat distribution treated with protease inhibitors are at high risk for abnormalities in glucose metabolism: A reason for glycemic control. European Journal of Medical Research 13 (2008) 209-214
5. Brar I., Shuter J., Thomas A., Daniels E., Absalon J., and Minorities and Women's Task Force of Terry Beirn Community Programs for Clinical Research on AIDS. A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the national health and nutritional examination survey cohort. Journal of Acquired Immune Deficiency Syndromes 45 (2007) 66-71
6. Carr A., Samaras K., Burton S., Law M., Freund J., Chisholhm D., et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 14 (1998) F25-F32
7. Centers for Disease Control and Prevention. Adult participation in recommended levels of physical activity-United States, 2001 and 2003. Morbidity Mortality Weekly Report 54 (2005) 1208-1212
8. Currier J.S., Lundgren J.D., Carr A., Klein D., Sabin C.A., Sax P.E., et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 118 (2008) e29-e35
9. Danoff A., Shi Q., Justman J., Mulligan K., Hessol N., Robison E., et al. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. Journal of Acquired Immune Deficiency Syndromes 39 (2005) 55-62
10. Dreschler H., and Powderly W.G. Switching effective antiretroviral therapy: A review. Clinical Infectious Diseases 35 (2002) 1219-1230
11. Engleson E.S., Kotler D.P., Tan Y., Agin D., Wang J., Pierson R.N., et al. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging. American Journal of Clinical Nutrition 69 (1999) 1162-1169
12. Falutz J., Allas S., Blot K., Potvin D., Kotler D., Somero M., et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine 357 (2007) 2359-2370
13. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among U.S. adults. Journal of the American Medical Association 287 (2002) 356-359
14. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109 (2004) 433-438
15. Hadigan C., Meigs J.B., Corcoran C., Rietschel P., Piecuch S., Basgoz N., et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clinical Infectious Diseases 32 (2001) 130-139
16. Hadigan C., Meigs J.B., Wilson P.W., D'Agostino R.B., Davis B., Basgoz N., et al. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Clinical Infectious Diseases 36 (2003) 909-916
17. Hadigan C., Miller K., Corcoran C., Anderson E., Basgoz N., and Grinspoon S. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. Journal of Clinical Endocrinology & Metabolism 84 (1999) 1932-1937
18. Haskell W.L., Lee I.M., Pate R.R., Powell K.E., Blair S.N., Franklin B.A., et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Medicine and Science in Sports Exercise 39 (2007) 1423-1434
19. Heath K.V., Hogg R.S., Singer J., Chan K.J., O'Shaughnessy M.W., and Montaner J.S. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based cohort. Journal of Acquired Immune Deficiency Syndrome 30 (2002) 440-447
20. Hendricks K.M., Willis K., Houser R., and Jones C.Y. Obesity in HIV-infection: Dietary correlates. Journal of the American College of Nutrition 25 (2006) 321-331
21. Hodgson L.M., Ghattas H., Pritchitt H., Schwenk A., Payne L., and Macallan D.C. Wasting and obesity in HIV outpatients. AIDS 15 (2001) 2341-2342
22. Hollis J.F., Gullion C.M., Stevens V.J., Brantley P.J., Appel L.J., Ard J.D., et al. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. American Journal of Preventive Medicine 35 (2008) 118-126
23. Innes K.E., Vincent H.K., and Taylor A.G. Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part 2: A potential role for mind-body therapies. Alternative Therapies in Health and Medicine 13 (2007) 44-51
24. Jacobson D.L., Tang A.M., Spiegelman D., Thomas A.M., Skinner S., Gorbach S.L., et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the U.S. population. Journal of Acquired Immune Deficiency Syndromes 43 (2006) 458-466
25. Jones C.Y., Hogan J.W., Snyder B., Klein R.S., Rompalo A., Schuman P., et al. Overweight and human immunodeficiency virus (HIV) progression in women: Associations between HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clinical Infectious Diseases 37 Suppl. 2 (2003) S69-S80
26. Jones C.Y., Wilson I.B., Greenberg A.S., Shevitz A., Knox T.A., Gorbach S.L., et al. Insulin resistance in HIV-infected men and women in the nutrition for healthy living cohort. Journal of Acquired Immune Deficiency Syndromes 40 (2005) 202-211
27. Justman J.E., Hoover D.R., Shi Q., Tan T., Anastos K., Tien P.C., et al. Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women. Journal of Acquired Immune Deficiency Syndromes 47 (2008) 312-319
28. Kaplan R.C., Kingsley L.A., Sharrett A.R., Li X., Lazar J., Tien P.C., et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clinical Infectious Diseases 45 (2007) 1074-1081
29. Khunnawat C., Mukerji S., Havlichek D., Touma R., and Abela G.S. Cardiovascular manifestations in human immunodeficiency virus-infected patients. American Journal of Cardiology 102 (2008) 635-642
30. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 364 (2002) 393-403
31. Kohli R., Shevitz A., Gorbach S., and Wanke C. A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy. HIV Medicine 8 (2007) 420-426
32. Kotler D.P., Rosenbaum K., Wang J., and Pierson R.N. Studies of body composition and fat distribution in HIV-infected and control subjects. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 20 (1999) 228-237
33. Kumanyika S.K., Obarzenek E., Stettler N., Bell R., Field A.E., Fortmann S.P., et al. Population-based prevention of obesity: The need for comprehensive promotion of healthful eating, physical activity, and energy balance. Circulation 118 (2008) 428-464
34. Lin B., and Guthrie J.E. Nutrient contribution of food away from home (1999), U.S. Department of Agriculture, Economic Research Service, Washington, DC
35. Lo J., You S.M., Canavan B., Liebau J., Beltrani G., Koutkia P., et al. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: A randomized controlled trial. Journal of the American Medical Association 300 (2008) 509-519
36. Mondy K., Overton E.T., Grubb J., Tong S., Seyfried W., Powderly W., et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern U.S. outpatient population. Clinical Infectious Diseases 44 (2007) 726-734
37. Moyle G.J. Plastic surgical approaches for HIV-associated lipoatrophy. Current HIV/AIDS Reports 2 (2005) 127-131
38. Mu H., Chai H., Lin P., Yao Q., and Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World Journal of Surgery 31 (2007) 632-643
39. National Heart, Lung, and Blood Institute Education Initiative. The practical guide: Identification, evaluation, and treatment of overweight and obesity in adults (2000), National Institutes of Health, Washington, DC
40. National Heart, Lung, and Blood Institute. (2008). Portion distortion. Retrieved September 23, 2008, from http://hp2010.nhlbihin.net/portion/
41. Nieuwenhuizen A.G., and Rutters F. The hypothalamic-pituitary-adrenal-axis in the regulation of energy balance. Physiology and Behavior 94 (2008) 69-177
42. O'Brien K., Nixon S., Glazier R.H., and Tynan A.M. Progressive resistive exercise interventions for adults living with HIV/AIDS. Cochrane Database of Systematic Reviews 2 (2007)
43. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. Journal of the American Medical Association 295 (2006) 1549-1555
44. Pao V., Lee G.A., and Grunfeld C. HIV therapy, metabolic syndrome, and cardiovascular risk. Current Atherosclerosis Reports 10 (2008) 61-70
45. Samaras K., Wand H., Law M., Emery S., Cooper D., and Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria. Diabetes Care 30 (2007) 113-119
46. Shai I., Schwarzfuch D., Henkin Y., Shahar D., Witkow S., Greenberg I., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. The New England Journal of Medicine 359 (2008) 229-241
47. Shaw K., O'Rourke P., Del Mar C., and Kenardy J. Psychological interventions for overweight or obesity. Cochrane Database of Systematic Reviews, 2, CD003818 (2005)
48. Shevitz, A.H., & Knox, T.A. (2001). Nutrition in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 32, 1769-1775. Erratum in Clinical Infectious Diseases, 33, 1445.
49. Shor-Posner G., Campa A., Zhang G., Persaud N., Miguez-Burbano M.J., Quesada J., et al. When obesity is desirable: A longitudinal study of the Miami HIV-1-infected drug abusers (MIDAS) cohort. Journal of Acquired Immune Deficiency Syndromes 23 (2000) 81-88
50. Shuter J., Chang C.J., and Klein R.S. Prevalence and predictive value of overweight in an urban HIV care clinic. Journal of Acquired Immune Deficiency Syndromes 26 (2001) 291-297
51. Tang A.M., Jacobson D.L., Spiegelman D., Knox T.A., and Wanke C. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003. Journal of Acquired Immune Deficiency Syndromes 40 (2005) 70-76
52. Torres S.J., and Nowson C.A. Relationship between stress, eating behavior, and obesity. Nutrition 23 (2007) 887-894
53. Wohl D.A., McComsey G., Tebas P., Brown T.T., Glesby M.J.M., Reeds D., et al. Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. HIV/AIDS 43 (2006) 645-653
54. World Health Organization. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Retrieved September 20, 2008, from http://www.staff.ncl.ac.uk/philip.home/who_dmc.htm